The antiserum was produced against synthesized peptide derived from human EFEMP2. AA range:91-140
Alternative Names:
EFEMP2, FBLN4, EGF-containing fibulin-like extracellular matrix protein 2, Fibulin-4, FIBL-4, Protein UPH1
A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fa
